PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 31, 20250 citationsOpen Access

Enhancing Clinical Classification of Protein Variants using ESM2 and UMAP

View Full Paper
LULomoio UgoPVPierangelo VeltriPGPietro Hiram Guzzi

Key Points

  • MAIN FINDING: Integrating ESM2 with UMAP improves classification accuracy for protein variants in genomic analysis.
  • KEY EVIDENCE: Results show enhanced separability of benign versus pathogenic variants based on protein structure.
  • APPROACH: The study uses ESM2 representations with UMAP for high-dimensional visualization of protein sequences.
  • SIGNIFICANCE: This method offers a scalable and interpretable framework for prioritizing variants in precision medicine.

Abstract

Protein sequences can vary due to mutations in their coding DNA sequence, resulting in differences in structure and function. A single protein may exist in multiple variant forms, each potentially leading to distinct phenotypic consequences depending on how the alterations affect its structure, function, or expression. Missense variants are single-nucleotide substitutions in the DNA sequence that cause the replacement of one amino acid with another in the corresponding protein, potentially affecting its structure, stability, and function. The clinical interpretation of missense variants in protein-coding regions remains a challenge in genomic medicine. Recent advances in protein language models and manifold learning offer new opportunities for the unsupervised extraction of biologically relevant information from protein sequences. This study integrates representations derived from Evolutionary Scale Modeling (ESM2), a family of large-scale protein language models, with nonlinear dimensionality reduction via Uniform Manifold Approximation and Projection (UMAP), a technique used to visualize high-dimensional data, to improve the classification of variants of uncertain significance (VUS) in disease-associated proteins. Our results suggest that this approach enhances the separability of benign and pathogenic variants, offering a scalable and interpretable strategy for variant prioritization in precision medicine.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ugo et al. (2025) studied this question.

synapsesocial.com/papers/689a0c65e6551bb0af8cf874https://doi.org/10.1101/2025.07.26.666924
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1MutaBind2: Predicting the Impacts of Single and Multiple Mutations on Protein-Protein Interactions2020 · 224 citations
  2. 2MTR-Viewer: identifying regions within genes under purifying selection2019 · 71 citations
  3. 3Cardiovascular Genetics and Genomics2018 · 10 citations
  4. 4ADDRESS: A Database of Disease-associated Human Variants Incorporating Protein Structure and Folding Stabilities2021 · 28 citations
  5. 5Deregulated Regulators: Disease-Causing cis Variants in Transcription Factor Genes2020 · 59 citations